MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142–3p and miR-129–5p

References

• Ottaviani G, Jaffe N. The epidemiology of osteosarcoma. Cancer Treat Res 2009; 152:3-13; PMID:20213383; http://dx.doi.org/10.1007/978-1-4419-0284-9_1
   PubMedGoogle Scholar
• Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F, et al. Landscape of transcription in human cells. Nature 2012; 489:101-8; PMID:22955620; http://dx.doi.org/10.1038/nature11233
   PubMed Web of Science ®Google Scholar
• Martens-Uzunova ES, Bottcher R, Croce CM, Jenster G, Visakorpi T, Calin GA. Long noncoding RNA in prostate, bladder, and kidney cancer. Eur Urol 2014; 65:1140-51; PMID:24373479; http://dx.doi.org/10.1016/j.eururo.2013.12.003
   PubMed Web of Science ®Google Scholar
• Zheng Z, Ding M, Ni J, Song D, Huang J, Wang J. MiR-142 acts as a tumor suppressor in osteosarcoma cell lines by targeting Rac1. Oncol Rep 2015; 33:1291-9; PMID:25530132; http://dx.doi.org/10.3892/or.2014.3687
   PubMed Web of Science ®Google Scholar
• Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell 2009; 136:629-41; PMID:19239885; http://dx.doi.org/10.1016/j.cell.2009.02.006
   PubMed Web of Science ®Google Scholar
• Di Gesualdo F, Capaccioli S, Lulli M. A pathophysiological view of the long non-coding RNA world. Oncotarget 2014; 5:10976-96; PMID:25428918; http://dx.doi.org/10.18632/oncotarget.2770
   PubMed Web of Science ®Google Scholar
• Zhou S, Wang J, Zhang Z. An emerging understanding of long noncoding RNAs in kidney cancer. J Cancer Res Clin Oncol 2014; 140:1989-95; PMID:24816785; http://dx.doi.org/10.1007/s00432-014-1699-y
   PubMed Web of Science ®Google Scholar
• Malek E, Jagannathan S, Driscoll JJ. Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer. Oncotarget 2014; 5:8027-38; PMID:25275300; http://dx.doi.org/10.18632/oncotarget.2469
   PubMed Web of Science ®Google Scholar
• Bhan A, Mandal SS. LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer. Biochim Biophys Acta 2015; 1856:151-64; PMID:26208723; http://dx.doi.org/10.1016/j.bbcan.2015.07.001
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu Z, Yao B, Dou C, Xu M, Xue Y, Ding L, Jia Y, Zhang H, Li Q, et al. Long non-coding RNA TUSC7 acts a molecular sponge for miR-10a and suppresses EMT in hepatocellular carcinoma. Tumour Biol 2016; 37:11429-41; doi: http://dx.doi.org/10.1007/s13277-016-4892-6
   PubMed Web of Science ®Google Scholar
• Qi P, Xu MD, Shen XH, Ni SJ, Huang D, Tan C, Weng WW, Sheng WQ, Zhou XY, Du X. Reciprocal repression between TUSC7 and miR-23b in gastric cancer. Int J Cancer 2015; 137:1269-78; PMID:25765901; http://dx.doi.org/10.1002/ijc.29516
   PubMed Web of Science ®Google Scholar
• Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: A new frontier in the study of human diseases. Cancer Lett 2013; 339:159-66; PMID:23791884; http://dx.doi.org/10.1016/j.canlet.2013.06.013
   PubMed Web of Science ®Google Scholar
• Li T, Mo X, Fu L, Xiao B, Guo J. Molecular mechanisms of long noncoding RNAs on gastric cancer. Oncotarget 2016; 7:8601-12; PMID:26788991; http://dx.doi.org/10.18632/oncotarget.6926
   PubMed Web of Science ®Google Scholar
• Cai X, Liu Y, Yang W, Xia Y, Yang C, Yang S, Liu X. Long noncoding RNA MALAT1 as a potential therapeutic target in osteosarcoma. J Orthop Res 2016; 34:932–41; PMID:26575981; http://dx.doi.org/10.1002/jor.23105
   Google Scholar
• Dong Y, Liang G, Yuan B, Yang C, Gao R, Zhou X. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway. Tumour Biol 2015; 36:1477-86; PMID:25431257; http://dx.doi.org/10.1007/s13277-014-2631-4
   Google Scholar
• Huang J, Liu K, Yu Y, Xie M, Kang R, Vernon P, Cao L, Tang D, Ni J. Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma. Autophagy 2012; 8:275-7; PMID:22301993; http://dx.doi.org/10.4161/auto.8.2.18940
   PubMed Web of Science ®Google Scholar
• Gutschner T, Hammerle M, Diederichs S. MALAT1 – a paradigm for long noncoding RNA function in cancer. J Mol Med (Berl) 2013; 91:791-801; PMID:23529762; http://dx.doi.org/10.1007/s00109-013-1028-y
   PubMed Web of Science ®Google Scholar
• Shrivastava S, Mansure JJ, Almajed W, Cury F, Ferbeyre G, Popovic M, Seuntjens J, Kassouf W. The role of HMGB1 in radioresistance of bladder cancer. Mol Cancer Ther 2016; 15:471-9; PMID:26719575; http://dx.doi.org/10.1158/1535-7163.MCT-15-0581
   PubMed Web of Science ®Google Scholar
• Yang GL, Zhang LH, Bo JJ, Huo XJ, Chen HG, Cao M, Liu DM, Huang YR. Increased expression of HMGB1 is associated with poor prognosis in human bladder cancer. J Surg Oncol 2012; 106:57-61; PMID:22237993; http://dx.doi.org/10.1002/jso.23040
   PubMed Web of Science ®Google Scholar
• Tee AE, Liu B, Song R, Li J, Pasquier E, Cheung BB, Jiang C, Marshall GM, Haber M, Norris MD, et al. The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression. Oncotarget 2016; 7:8663-75; PMID:26848616; http://dx.doi.org/10.18632/oncotarget.6675
   PubMed Web of Science ®Google Scholar
• Yang MH, Hu ZY, Xu C, Xie LY, Wang XY, Chen SY, Li ZG. MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9. Biochim Biophys Acta 2015; 1852:166-74; PMID:25446987; http://dx.doi.org/10.1016/j.bbadis.2014.11.013
   PubMed Web of Science ®Google Scholar
• Xiao H, Tang K, Liu P, Chen K, Hu J, Zeng J, Xiao W, Yu G, Yao W, Zhou H, et al. LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma. Oncotarget 2015; 6:38005-15; PMID:26461224; http://dx.doi.org/10.18632/oncotarget.5357
   PubMed Web of Science ®Google Scholar
• Wang X, Li M, Wang Z, Han S, Tang X, Ge Y, Zhou L, Zhou C, Yuan Q, Yang M. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells. J Biol Chem 2015; 290:3925-35; PMID:25538231; http://dx.doi.org/10.1074/jbc.M114.596866
   PubMed Web of Science ®Google Scholar
• Huang J, Ni J, Liu K, Yu Y, Xie M, Kang R, Vernon P, Cao L, Tang D. HMGB1 promotes drug resistance in osteosarcoma. Cancer Res 2012; 72:230-8; PMID:22102692; http://dx.doi.org/10.1158/0008-5472.CAN-11-2001
   PubMed Web of Science ®Google Scholar
• Zhang C, Ge S, Hu C, Yang N, Zhang J. MiRNA-218, a new regulator of HMGB1, suppresses cell migration and invasion in non-small cell lung cancer. Acta Biochim Biophys Sin (Shanghai) 2013; 45:1055-61; PMID:24247270; http://dx.doi.org/10.1093/abbs/gmt109
   PubMed Web of Science ®Google Scholar
• Yang Y, Huang JQ, Zhang X, Shen LF. MiR-129-2 functions as a tumor suppressor in glioma cells by targeting HMGB1 and is down-regulated by DNA methylation. Mol Cell Biochem 2015; 404:229-39; PMID:25772485; http://dx.doi.org/10.1007/s11010-015-2382-6
   PubMed Web of Science ®Google Scholar
• Xiao P, Liu WL. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma. Int J Clin Exp Pathol 2015; 8:10800-7; PMID:26617792
   PubMed Web of Science ®Google Scholar
• Luo J, Chen J, He L. mir-129-5p attenuates irradiation-induced autophagy and decreases radioresistance of breast cancer cells by targeting HMGB1. Med Sci Monit 2015; 21:4122-9; PMID:26720492; http://dx.doi.org/10.12659/MSM.896661
   PubMed Web of Science ®Google Scholar
• Schwickert A, Weghake E, Bruggemann K, Engbers A, Brinkmann BF, Kemper B, Seggewiss J, Stock C, Ebnet K, Kiesel L, et al. microRNA miR-142-3p inhibits breast cancer cell invasiveness by synchronous targeting of WASL, integrin alpha V, and additional cytoskeletal elements. PLoS One 2015; 10:e0143993; PMID:26657485; http://dx.doi.org/10.1371/journal.pone.0143993
   PubMed Web of Science ®Google Scholar
• Lei Z, Xu G, Wang L, Yang H, Liu X, Zhao J, Zhang HT. MiR-142-3p represses TGF-beta-induced growth inhibition through repression of TGFbetaR1 in non-small cell lung cancer. FASEB J 2014; 28:2696-704; PMID:24558198; http://dx.doi.org/10.1096/fj.13-247288
   PubMed Web of Science ®Google Scholar
• Chai S, Tong M, Ng KY, Kwan PS, Chan YP, Fung TM, Lee TK, Wong N, Xie D, Yuan YF, et al. Regulatory role of miR-142-3p on the functional hepatic cancer stem cell marker CD133. Oncotarget 2014; 5:5725-35; PMID:25015418; http://dx.doi.org/10.18632/oncotarget.2167
   PubMed Web of Science ®Google Scholar
• Bijnsdorp IV, Hodzic J, Lagerweij T, Westerman B, Krijgsman O, Broeke J, Verweij F, Nilsson RJ, Rozendaal L, van Beusechem VW, et al. miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110. Oncotarget 2016; 7:16676-87; PMID:26918338; http://dx.doi.org/10.18632/oncotarget.7572
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang Y, Wei Y, Li M, Yu S, Ye M, Zhang H, Chen S, Liu W, Zhang J. MiR-129-3p promotes docetaxel resistance of breast cancer cells via CP110 inhibition. Sci Rep 2015; 5:15424; PMID:26487539; http://dx.doi.org/10.1038/srep15424
   PubMed Web of Science ®Google Scholar
• Wang X, Guo Y, Wang C, Yu H, Yu X. MicroRNA-142-3p inhibits chondrocyte apoptosis and inflammation in osteoarthritis by targeting HMGB1. Inflammation 2016; 39:1718–28; PMID:27447821; http://dx.doi.org/10.1007/s10753-016-0406-3
   Web of Science ®Google Scholar
• Yang L, Bai HS, Deng Y, Fan L. High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion. Eur Rev Med Pharmacol Sci 2015; 19:3187-93.
   PubMed Web of Science ®Google Scholar
• Hirata H, Hinoda Y, Shahryari V, Deng G, Nakajima K, Tabatabai ZL, Ishii N, Dahiya R. Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205. Cancer Res 2015; 75:1322-31; PMID:25600645; http://dx.doi.org/10.1158/0008-5472.CAN-14-2931
   PubMed Web of Science ®Google Scholar
• Yang G, Zhang P, Lv A, Liu Y, Wang G. MiR-205 functions as a tumor suppressor via targeting TGF-alpha in osteosarcoma. Exp Mol Pathol 2016; 100:160-6; PMID:26708425; http://dx.doi.org/10.1016/j.yexmp.2015.12.010
   PubMed Web of Science ®Google Scholar